ABSTRACT
Liver transplantation is a rational therapeutic option for irreversible liver damage due to acute liver failure (ALF) and chronic liver disease. Of the approximately 4000 liver transplants carried out annually in the USA, chronic hepatitis C, often with alcoholic liver disease, accounts for up to 30% whereas hepatitis B accounts for around 5%.
